Gary Kobinger, Ph.D. ProfessorDepartment of Microbiology and Infectious Diseases

y of Laval Director of Research Centre on Infectious Diseases

DISTINGUISHED LECTURE SERIESInstitut Lady Davis de recherches médicales | Lady Davis Institute for Medical Research

Vaccine development against Ebola, Zika and HIVTuesday, April 2412:00 pm – 1:00 pmLDI BLOOMFIELD LECTURE HALL, F-4 (Ground Floor)

3999, Chemin de la Côte-Ste-Catherine (Corner of Legaré) Montréal, Québec H3T 1E2 CANADA (Conférence en anglais seulement)

Gary Kobinger is a professor in the Department of Microbiology and Infectious Diseases and the Director of the Research Centre on Infectious Diseases, Faculty of Medicine at Université Laval. He is also an adjunct professor in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania, and an associate professor in the Department of Medical Microbiology at the University of Manitoba. His work focuses on developing and testing new vaccine platforms and immune treatments against emerging and re-emerging viruses of high consequences to public health. Gary’s goal as Director is to develop a research framework that can respond rapidly to emerging and re-emerging pathogens.

Gary Kobinger's work focuses on developing and testing new vaccine platforms and immune treatments against emerging and re-emerging viruses of high consequences to public health. A main objective is to develop a research framework that can respond rapidly to emerging and re-emerging pathogens. Contributing to the generation and clinical progression of Ebola vaccines and treatments, Gary’s team is now working on mitigating infections from several pathogens such as CCHF, Lassa, MERS, HIV and Zika.

Dr. Andrew Mouland x24847 / e-mail: andrew.mouland@mcgill.ca